Dilemmas in the diagnosis and pathogenesis of atypical late‐onset familial haemophagocytic lymphohistiocytosis

por Minson, Adrian, Voskoboinik, Ilia, Grigg, Andrew
Publicado 2021

Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas

por Minson, Adrian, Tam, Constantine, Dickinson, Michael, Seymour, John F.
Publicado 2022

P1066: PEMBROLIZUMAB MONOTHERAPY AS A FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD INELIGIBLE PATIENTS, DOES NOT PRECLUDE SUBSEQUENT THERAPY, AND PROVIDES ADE...

por Dickinson, Michael, Berkahn, Leanne, Trotman, Judith, Butler, Jason, Neeson, Paul, Bressel, Matthias, Minson, Adrian
Publicado 2023

P1156: IN THE ABSENCE OF SYMPTOMS OR CEREBROSPINAL FLUID INVOLVEMENT, MRI STAGING OF THE CENTRAL NERVOUS SYSTEM (CNS) IN PATIENTS WITH SYSTEMIC DIFFUSE LARGE B-CELL LYMPHOMA RARELY...

por Juneja, Manu, Bennett, Rory, Ann Anderson, Mary, Minson, Adrian, Wolf, Max, Herbert, Kirsten, Lieschke, Graham J, Roberts, Andrew, Mason, Kylie, Seymour, John, Dickinson, Michael
Publicado 2023

Bi-Allelic Mutations in STXBP2 Reveal a Complementary Role for STXBP1 in Cytotoxic Lymphocyte Killing

por Lopez, Jamie A., Noori, Tahereh, Minson, Adrian, Li Jovanoska, Lu, Thia, Kevin, Hildebrand, Michael S., Akhlaghi, Hedieh, Darcy, Phillip K., Kershaw, Michael H., Brown, Natasha J., Grigg, Andrew, Trapani, Joseph A., Voskoboinik, Ilia
Publicado 2018

P1117: GLOFITAMAB PLUS R-CHOP OR POLATUZUMAB VEDOTIN-R-CHP IS DELIVERABLE AND YIELDS HIGH OVERALL RESPONSE IN PATIENTS <=65 YEARS OF AGE WITH HIGH-RISK DLBCL OR HGBL: INTERIM ANALY...

por Minson, Adrian, Verner, Emma, Giri, Pratyush, Min Wong, Shu, Ratnasingam, Sumita, Butler, Jason, Janowski, Wojciech, Ku, Matthew, Cheah, Chan, Hertzberg, Mark, Herbert, Kirsten, Hamad, Nada, Yannakou, Costas, Neeson, Paul, Saghebi, Javad, Blombery, Piers, Robertson, Molly, Shong Lau, Lei, Xie, Jing, Seymour, John, Dickinson, Michael
Publicado 2023